129 related articles for article (PubMed ID: 16971316)
21. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
22. Molecular changes following topical photodynamic therapy using methyl aminolaevulinate in mouse skin.
Choi JY; Park GT; Na EY; Wi HS; Lee SC; Lee JB
J Dermatol Sci; 2010 Jun; 58(3):198-203. PubMed ID: 20434314
[TBL] [Abstract][Full Text] [Related]
23. A comparison of intense pulsed light, combination radiofrequency and intense pulsed light, and blue light in photodynamic therapy for acne vulgaris.
Taub AF
J Drugs Dermatol; 2007 Oct; 6(10):1010-6. PubMed ID: 17966178
[TBL] [Abstract][Full Text] [Related]
24. Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source.
Gold MH; Biron JA; Boring M; Bridges TM; Bradshaw VL
J Drugs Dermatol; 2007 Mar; 6(3):319-22. PubMed ID: 17373194
[TBL] [Abstract][Full Text] [Related]
25. A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.
Gold MH; Biron J
J Drugs Dermatol; 2006 Sep; 5(8):796-8. PubMed ID: 16989195
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy against common bacteria causing wound and skin infections.
Wardlaw JL; Sullivan TJ; Lux CN; Austin FW
Vet J; 2012 Jun; 192(3):374-7. PubMed ID: 22000592
[TBL] [Abstract][Full Text] [Related]
27. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
28. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
[TBL] [Abstract][Full Text] [Related]
29. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial.
Borelli C; Herzinger T; Merk K; Berking C; Kunte C; Plewig G; Degitz K
Dermatol Surg; 2007 Mar; 33(3):314-8. PubMed ID: 17338689
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
Hayami J; Okamoto H; Sugihara A; Horio T
J Dermatol; 2007 May; 34(5):320-7. PubMed ID: 17408441
[TBL] [Abstract][Full Text] [Related]
31. Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis.
Kim JY; Kang HY; Lee ES; Kim YC
J Dermatol; 2007 Jan; 34(1):37-40. PubMed ID: 17204099
[TBL] [Abstract][Full Text] [Related]
32. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT.
Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H
Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444
[TBL] [Abstract][Full Text] [Related]
33. Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
Babilas P; Travnik R; Werner A; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Jan; 6(1):25-32. PubMed ID: 17995967
[TBL] [Abstract][Full Text] [Related]
34. Pain induced by photodynamic therapy of warts.
Stender IM; Borgbjerg FM; Villumsen J; Lock-Andersen J; Wulf HC
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):304-9. PubMed ID: 17100738
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial photodynamic therapy in dermatology.
Maisch T; Szeimies RM; Jori G; Abels C
Photochem Photobiol Sci; 2004 Oct; 3(10):907-17. PubMed ID: 15480480
[TBL] [Abstract][Full Text] [Related]
36. Skin fluorescence controlled photodynamic photorejuvenation (wrinkle reduction).
Bjerring P; Christiansen K; Troilius A; Bekhor P; de Leeuw J
Lasers Surg Med; 2009 Jul; 41(5):327-36. PubMed ID: 19533757
[TBL] [Abstract][Full Text] [Related]
37. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
38. A review of photodynamic therapy (PDT) for the treatment of acne vulgaris.
Riddle CC; Terrell SN; Menser MB; Aires DJ; Schweiger ES
J Drugs Dermatol; 2009 Nov; 8(11):1010-9. PubMed ID: 19894368
[TBL] [Abstract][Full Text] [Related]
39. Ultrastructural alteration of tape-stripped normal human skin after photodynamic therapy.
Bartosik J; Stender IM; Kobayasi T; Agren MS
Eur J Dermatol; 2004; 14(2):91-5. PubMed ID: 15196998
[TBL] [Abstract][Full Text] [Related]
40. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system.
Zawislak AA; McCluggage WG; Donnelly RF; Maxwell P; Price JH; Dobbs SP; McClelland HR; Woolfson AD; Mccarron PA
Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):111-3. PubMed ID: 19292790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
